Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2018-11-16

CHMP recommends first oral-only treatment for sleeping sickness

View source ↗

Summary

The CHMP recommends an oral-only treatment option for sleeping sickness, signaling a potential shift to easier, non-injectable therapy for the disease in Europe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications